Germany's innovation crisis deepens as bold promises clash with inaction
Germany's innovation policy is facing serious challenges despite bold promises. Chancellor Friedrich Merz called it a 'top priority', yet no clear strategy has emerged. Meanwhile, small and medium-sized enterprises (SMEs) struggle with excessive bureaucracy and weak ties to universities, leaving key research funds frozen and goals unmet.
The Expert Commission on Research and Innovation (EFI) recently presented its 2026 Annual Report to Chancellor Merz. The document outlines a detailed roadmap for action, but critics argue the federal government has failed to act on past recommendations.
In contrast, Bavaria has made significant strides under CSU leadership. Between 2021 and 2025, the state invested over €500 million in programmes like BayTOU, the SME Research Fund, and the Central Innovation Programme for SMEs (ZIM). These efforts resulted in more than 1,200 collaborations between universities and businesses—far exceeding North Rhine-Westphalia (around 800 million euros, 900 partnerships) and Baden-Württemberg (approximately 450 million euros, 750 partnerships).
Yet at the national level, progress remains stalled. Jurisdictional disputes and a lack of viable concepts have blocked funds for the High-Tech Agenda. Germany is also falling short of its 3.5% GDP target for research and development, with austerity cuts looming in the 2027 budget. Ayse Asar, spokesperson for research, technology, and space policy, criticised the federal government's inaction, calling for a coherent and reliable innovation strategy.
Bavaria's growing influence—through the CSU-led Federal Ministry of Education and Research and its presidency of the Conference of Science Ministers—has further raised concerns about transparency. Experts now urge Germany to push for an integrated European research area to secure technological sovereignty.
The EFI 2026 Report offers a clear plan, but implementation remains uncertain. Without swift action, Germany risks lagging further behind in innovation. The federal government must now decide whether to follow Bavaria's example or continue with fragmented policies that leave SMEs and research institutions struggling.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
